BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 464018)

  • 1. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
    Ciocca DR; Puy LA; Fasoli LC
    Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma.
    Lindahl B; Alm P; Borg A; Fernö M; Grundsell H; Johnsson JE; Norgren A; Tropé C
    Anticancer Res; 1982; 2(4):203-7. PubMed ID: 7149649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid receptors and endometrial cancer.
    Soper JT; Christensen CW
    Clin Obstet Gynaecol; 1986 Dec; 13(4):825-42. PubMed ID: 3539444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endometrial cancer and steroid hormone receptors].
    Nyholm HC
    Ugeskr Laeger; 1990 Feb; 152(9):593-7. PubMed ID: 2408223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex steroid receptors in endometrial cancer.
    Chambers JT
    Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor.
    Segreti EM; Novotny DB; Soper JT; Mutch DG; Creasman WT; McCarty KS
    Obstet Gynecol; 1989 May; 73(5 Pt 1):780-5. PubMed ID: 2704506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
    Kleine W; Fuchs A; deGregorio G; Geyer H
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical study of progesterone receptors in hyperplastic and neoplastic endometrial tissues.
    Bergeron C; Ferenczy A; Toft DO; Shyamala G
    Cancer Res; 1988 Nov; 48(21):6132-6. PubMed ID: 3167859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical receptor findings in the endometrium and therapeutic consequences in endogenous and exogenous functional disorders and cancer].
    Lang G; Lang M; Dallenbach-Hellweg G
    Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1044-9. PubMed ID: 2612844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormone receptor content and lymph node status in endometrial cancer.
    Morris PC; Anderson JR; Anderson B; Buller RE
    Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
    Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
    Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma.
    Creasman WT; McCarty KS; Barton TK; McCarty KS
    Obstet Gynecol; 1980 Mar; 55(3):363-70. PubMed ID: 7189047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of estrogen receptor levels in endometrial cancer cells.
    Gurpide E; Blumenthal R; Fleming H
    Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal therapy of endometrial cancer].
    Kato J
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1182-8. PubMed ID: 4057575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.